The pharmaceutical industry faces big challenges in drug discovery today – rising costs, high failure rates, and increasingly complex target diseases.

Evotec's insights into GPCRs and waveRAPID technology reveal new opportunities in drug discovery, focusing on orphan ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

Insilico Medicine, the biotech company with twin headquarters in Boston and Hong Kong, said it’s the first time an AI-created ...

How a single nitrogen atom could transform the future of drug discovery Jan 6, 2025 Iron and blue light enable rapid, low-toxicity creation of carbohydrates for new antibiotics ...

Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow. Founded in 2008, Gubra is a highly specialized preclinical CRO and biotech company ...

Machine learning and supercomputing have brought about a revolution in computational drug discovery. More therapeutic candidates, like antibodies that bind to and fight the SARS-CoV-2 virus, can be ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

Accelerating drug discovery with a single carbon atom. ScienceDaily . Retrieved May 31, 2025 from www.sciencedaily.com / releases / 2025 / 05 / 250506131509.htm ...

Despite significant progress in medicinal chemistry and life sciences research, drug discovery and development remain slow and expensive, taking on average approximately 15 years and US$2 billion ...

AI-driven drug discovery has gotten much of the glory in pharma. Isomorphic Labs — which is leveraging an AI drug discovery platform based on Nobel Prize-winning AlphaFold software — pulled in ...